ALSUntangled #75: Portable neuromodulation stimulator therapy

Spurred by patient interest, ALSUntangled herein examines the potential of the Portable Neuromodulation Stimulator (PoNS™) in treating amyotrophic lateral sclerosis (ALS). The PoNS™ device, FDA-approved for the treatment of gait deficits in adult patients with multiple sclerosis, utilizes translingual neurostimulation to stimulate trigeminal and facial nerves via the tongue, aiming to induce neuroplastic changes. While there are early, promising data for PoNS treatment to improve gait and balance in multiple sclerosis, stroke, and traumatic brain injury, no pre-clinical or clinical studies have been performed in ALS. Although reasonably safe, high costs and prescription requirements will limit PoNS accessibility. At this time, due to the lack of ALS-relevant data, we cannot endorse the use of PoNS as an ALS treatment.

Authors

Institutions

Publication Details

Journal
UNC Libraries
Published
2025-04-27
DOI
https://doi.org/10.17615/q4yc-w741
Primary Topic
Neurological disorders and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ALSUntangled #75: Portable neuromodulation stimulator therapy

Terry Heiman‐Patterson, Timothy Fullam, Sartaj Jhooty, Jesse Crayle et al.
UNC Libraries
Neurological disorders and treatments
article

ALSUntangled #75: Portable neuromodulation stimulator therapy

Terry Heiman‐Patterson, Timothy Fullam, Sartaj Jhooty, Jesse Crayle, Lyle W. Ostrow, John Sladky, Gregory T. Carter, Michael Benatar, Paul Wicks, Christopher J. McDermott, Eva L. Feldman, Robert Bowser, Gary L. Pattee, Dylan Ratner, Alexandra R. Linares, Carlayne E. Jackson, Tasnim Mushannen, Olimpia Carbunar, Carmel Armon, Javier Mascías Cadavid, Paul E. Barkhaus, Laurel Officer, Keelie Denson, Danelle Levinson, Xiaoyan Li, Ronak Patel, Yuyao Sun, Andrew Brown, Richard Bedlack, E. Mallon, Mark B. Bromberg, Tulio E. Bertorini, Morgan Beauchamp
article en

Abstract

Spurred by patient interest, ALSUntangled herein examines the potential of the Portable Neuromodulation Stimulator (PoNS™) in treating amyotrophic lateral sclerosis (ALS). The PoNS™ device, FDA-approved for the treatment of gait deficits in adult patients with multiple sclerosis, utilizes translingual neurostimulation to stimulate trigeminal and facial nerves via the tongue, aiming to induce neuroplastic changes. While there are early, promising data for PoNS treatment to improve gait and balance in multiple sclerosis, stroke, and traumatic brain injury, no pre-clinical or clinical studies have been performed in ALS. Although reasonably safe, high costs and prescription requirements will limit PoNS accessibility. At this time, due to the lack of ALS-relevant data, we cannot endorse the use of PoNS as an ALS treatment.

UNC Libraries
University of North Carolina at Chapel Hill (US)
Openalex Percentile: Top 58%
Neurological disorders and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.